Education
About Us
Working with TipRanks
Follow Us
Altimmune Inc (ALT)
NASDAQ:ALT
Pemvidutide
Alcohol Liver Disease
Phase II
Recruiting
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Jun 05, 2025
―
Pemvidutide
Alcohol Use Disorder (Aud)
Phase II
Recruiting
RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
May 16, 2025
―
Pemvidutide
Non-Alcoholic Steatohepatitis (Nash)
Phase II
Active Not Recruiting
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Jul 24, 2023
―
Alt-801
Type 2 Diabetes
Phase I
Completed
ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
Nov 15, 2021
―
Metformin, Digoxin, Warfarin, Atorvastatin, Pemvidutide, Ethinylestradiol And Levonorgestrel
Nash - Nonalcoholic Steatohepatitis
Phase I
Completed
Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
Jul 14, 2021
―
Alt-801
Obesity, Nonalcoholic Steatohepatitis
Phase I
Completed
ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
Sep 16, 2020
―
Nasoshield
Healthy Volunteers
Phase I
Completed
NasoShield in Healthy Adults to Study Safety and Immunogenicity
Jun 01, 2020
―
Biothrax, Nasoshield
Healthy Volunteers
Phase I
Completed
NasoShield Study of Safety and Immunogenicity
Nov 21, 2017
―
Fp-02.2 Vaccine, Ic31® Adjuvant
Hepatitis B
Phase I
Completed
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Jul 06, 2015
―
Pandemic Influenza Vaccine
Influenza A Subtype H5n1 Infection
Phase I
Completed
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
Sep 17, 2008
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Altimmune Inc (ALT) have in its pipeline
ALT is currently developing the following drugs: Pemvidutide, Pemvidutide, Pemvidutide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.